புதுமைகள் குழு மீடியா தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புதுமைகள் குழு மீடியா தொடர்புகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புதுமைகள் குழு மீடியா தொடர்புகள் Today - Breaking & Trending Today

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap's Mental Health Technology

Mydecine Innovations Group, Inc., is pleased to announce that its subsidiary Mindleap Health a digital health platform and the world’s-first telemedicine application purpose-built for the psychedelic medicine industry, has filed a provisional patent for its technology platform in both The United States Patent and Trademark Office and the Canadian Intellectual Property Office. “As our company continues to innovate …
Mydecine Innovations Group, Inc., ( CSE:MYCO ) ( OTC:MYCOF ) ( FSE:0NFA ) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital health platform and the world’s-first telemedicine application purpose-built for the psychedelic medicine industry, has filed a provisional patent for its technology platform in both The United States Patent and Trademark Office (USPTO) and the Canadian Intellectual Property Office. ....

United States , Jack Bunce , Josh Bartch , Charles Lee , Joshua Bartch , Anne Donohoe Nick Opich , Mindleap Health , Corp Communication , Our Services , Mydecine Innovations Group Media Contacts , Mindleap Health Platform Services Disclaimer , Mindleap Health Inc , Trademark Office , Digital Mental Health , Canadian Securities Exchange , Canadian Intellectual Property Office , Mydecine Innovations Group Inc , Mindleap Services , Strategic Communications , Specialist Services , Mydecine Innovations Group , United States Patent , Canadian Intellectual Property , Chairman Josh , Mindleap Well Being , Innovations Group Media Contacts ,

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange
globalbankingandfinance.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalbankingandfinance.com Daily Mail and Mail on Sunday newspapers.

United States , Josh Bartch , Charles Lee , Joshua Bartch , Anne Donohoe Nick Opich , Mydecine Innovations Group Inc , Corp Communication , Mydecine Innovations Group Media Contacts , Mydecine Innovations Group , Strategic Communications , Health Canada , Conditional Approval , Innovations Group Media Contacts , Anne Donohoe , Nick Opich , Chief Executive Officer , Investor Relations , ஒன்றுபட்டது மாநிலங்களில் , சார்லஸ் லீ , கார்ப் தொடர்பு , மூலோபாய தகவல்தொடர்புகள் , ஆரோக்கியம் கனடா , நிபந்தனை ஒப்புதல் , புதுமைகள் குழு மீடியா தொடர்புகள் , அன்னே தொனொோே , தலைமை நிர்வாகி அதிகாரி ,

Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

Mydecine Innovations Group Appoints Josephine Wu to Board of Directors
Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced the appointment of Josephine Wu, Founder and CIO at Aionious Management, Ltd., to the Company’s Board of Directors. Josh Bartch, Chairman and CEO of Mydecine, stated, “The Board of Directors welcomes Ms. Josephine Wu …
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced the appointment of Josephine Wu, Founder and CIO at Aionious Management, Ltd., to the Company’s Board of Directors. ....

United States , Josephine Wu , Pan Asia , Michael Connolly , Josh Bartch , Charles Lee , Joshua Bartch , Anne Donohoe Nick Opich , Aionious Management Ltd , Corp Communication , Mydecine Innovations Group Inc , Company Board Of Directors , Mydecine Innovations Group Media Contacts , Aionious Management , Strategic Communications , Mydecine Innovations Group , Health Canada , Aionious Management Limited , Caveat Emptor , Innovations Group , Innovations Group Media Contacts , Nick Opich , Chief Executive Officer , Investor Relations , ஒன்றுபட்டது மாநிலங்களில் , ஜோசபின் வு ,

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange
Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced today that it has received Conditional Approval to migrate and uplist its common shares with the NEO Exchange . Final approval is subject to the Company fulfilling all of NEO’s listing requirements. With the impending …
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced today that it has received Conditional Approval to migrate and uplist its common shares with the NEO Exchange (“NEO”). Final approval is subject to the Company fulfilling all of NEO’s listing requiremen ....

United States , Josh Bartch , Charles Lee , Joshua Bartch , Anne Donohoe Nick Opich , Mydecine Innovations Group Inc , Corp Communication , Strategic Communications , Mydecine Innovations Group , Health Canada , Mydecine Innovations Group Media Contacts , Conditional Approval , Innovations Group , Innovations Group Media Contacts , Nick Opich , Chief Executive Officer , Investor Relations , ஒன்றுபட்டது மாநிலங்களில் , சார்லஸ் லீ , கார்ப் தொடர்பு , மூலோபாய தகவல்தொடர்புகள் , ஆரோக்கியம் கனடா , நிபந்தனை ஒப்புதல் , புதுமைகள் குழு , புதுமைகள் குழு மீடியா தொடர்புகள் , தலைமை நிர்வாகி அதிகாரி ,

Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries. As part of the agreement, ProPharma Group …
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and ....

United States , Matthew Weinberg , Josh Bartch , Charles Lee , Joshua Bartch , Anne Donohoe Nick Opich , Mydecine Innovations Group Inc , Corp Communication , Regulatory Affairs , Drug Administration , Mydecine Innovations Group Media Contacts , Strategic Communications , Mydecine Innovations Group , Propharma Group , Health Canada , Canadian Securities Exchange , Pharma Group , Innovations Group , Innovations Group Media Contacts , Nick Opich , Chief Executive Officer , Investor Relations , United States Securities Act , ஒன்றுபட்டது மாநிலங்களில் , மேத்யூ வெயின்பெர்க் , சார்லஸ் லீ ,